SL-AF Trial - (Six Lead Identification of Atrial Fibrillation [AF])

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 750 participants.

Also called NCT02401451

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose screening
Phase
Not applicable
Enrolled
  • 750 participants (enrolled count) (from the registry)
Sponsor
Cardiocity Limited (from the registry)
Registry
  • NCT NCT02401451
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
United Kingdom (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02401451. Allocation not applicable; no masking; primary purpose screening. Start 2014-10 (registry gives no type); primary completion 2016-03 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
SL-AF Trial - (Six Lead Identification of Atrial Fibrillation [AF])
Acronym
SL-AF
Intervention (Device)
RhythmPadGP
Lead sponsor
Cardiocity Limited (class: industry)

Record details

Record id
cardio:ct-nct02401451
Content hash
5a9e2b4f4220f800080c5f774c9983d725288fd91ee49a8deb3fbb3852e7ae7a